ReNetx Bio logo

ReNetx Bio

The company was founded based on the innovative technology from Dr. Stephen Strittmatter's work at Yale University to improve neurologic function after CNS injury – creating a significant and completely unmet need estimated at >$5B annually. The technology allows neurons to regrow by eliminating factors that inhibit growth.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.renetx.com
Founded2017
Disease Focus
Development Stage
STOCK CODENon Listed
Address
157 Church Street 19th Floor, CT, 06510
New Haven
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]